Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes
- PMID: 9074808
- DOI: 10.1021/tx960064g
Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes
Abstract
Aryl acetylenes have been investigated as inhibitors of cytochrome P450 (P450)-dependent alkoxyresorufin dealkylation dealkylation activities in liver microsomes prepared from rats exposed to beta-naphthoflavone, isosafrole, or phenobarbital. Many of the acetylenes investigated produce pseudo-first-order time-dependent and NADPH-dependent losses of the dealkylation activities characteristic of mechanism-based irreversible inactivation (suicide inhibition). Replacing the terminal hydrogen of aryl acetylenes with a methyl group to convert ethynes into propynes enhances the inhibition of P450 1A enzymes; in some instances, this modification converts a reversible inhibitor of P450s into a suicide inhibitor. In contrast, ethynes are more effective suicide inhibitors of P450 2B-dependent dealkylations than the corresponding propynes. Aryl acetylenes with an ethynyl group on the 2 position of naphthalene or on the 9 position of phenanthrene and arylalkyl acetylenes with alkyl chains containing 2, 3, or 4 methylene groups are selective inhibitors of P450 2B1/2B2 in liver microsomes from rats. Aryl acetylenes also act as suicide inhibitors of P450 1A2 in human liver microsomes, of purified P450 1A2 from rabbit or rat liver in reconstituted systems, and of purified recombinant human P450 1A2 and 1A1 in reconstituted systems. 4-(1-Propynyl)biphenyl (4PBi) inactivated P450 1A2-dependent ethoxyresourfin deethylation (EROD) activity in human liver microsomes in an NADPH-dependent process (k(inactivation), 0.23 min-1; KI, 2.3 microM). 4PBi also inactivated purified recombinant human P450 1A2 (k(inactivation), 0.24 min-1; KI, 4.3 microM). In agreement with previous reports [Yun, C.-H., Hammons, G. J., Jones, G., Martin, M. V., Hopkins, N. E., Alworth, W. L., and Guengerich, F. P. (1992) Biochemistry 31, 10556-10563], 2-ethynylnaphthalene (2EN) was not a suicide inhibitor of the P450 1A2 activity in human liver microsomes but did inactivate purified human P450 1A2. Neither 4PBi nor 2EN affected diagnostic activities of human microsomal P450 2E1, 2C9/10, 3A4, or 2C19. In the systems examined, the losses of P450-dependent activity produced by these aryl acetylenes were not accompanied by corresponding decreases in the measured P450 absorption spectra. Thus P450 inactivation by these aryl acetylenes does not involve labeling and destruction of the heme. Incubation of 4PBi with microsomal P450 1A1 or 1A2 from rat liver under conditions that lead to P450-dependent, enzyme inactivations generates a 2-biphenylylpropionic acid product. This suggests that the suicide inhibition of P450s by propynylaryl acetylenes proceeds via a methylaryl ketene formed by a 1,2-methyl rearrangement, analogous to the mechanism of suicide inhibition by ethynyl acetylenes that proceed via ketene intermediates formed by 1,2-hydrogen shifts [Ortiz de Montellano, P. R., and Kunze, K. L. (1981) Arch. Biochem. Biophys. 209, 710-712].
Similar articles
-
Suicide inhibitors of cytochrome P450 1A1 and P450 2B1.Biochem Pharmacol. 1992 Aug 18;44(4):787-96. doi: 10.1016/0006-2952(92)90417-h. Biochem Pharmacol. 1992. PMID: 1510726
-
A role for threonine 302 in the mechanism-based inactivation of P450 2B4 by 2-ethynylnaphthalene.Arch Biochem Biophys. 1996 Jul 15;331(2):170-6. doi: 10.1006/abbi.1996.0295. Arch Biochem Biophys. 1996. PMID: 8660695
-
Mechanism-based inactivation of cytochromes P450 2B1 and P450 2B6 by 2-phenyl-2-(1-piperidinyl)propane.Drug Metab Dispos. 2000 Aug;28(8):905-11. Drug Metab Dispos. 2000. PMID: 10901699
-
Mechanisms of cytochrome P450 1A2-mediated formation of N-hydroxy arylamines and heterocyclic amines and their reaction with guanyl residues.Princess Takamatsu Symp. 1995;23:78-84. Princess Takamatsu Symp. 1995. PMID: 8844798 Review.
-
Cytochrome P450 and its interactions with the heme biosynthetic pathway.Can J Physiol Pharmacol. 1996 Jan;74(1):1-8. Can J Physiol Pharmacol. 1996. PMID: 8963944 Review.
Cited by
-
Interaction of polycyclic aromatic hydrocarbons with human cytochrome P450 1B1 in inhibiting catalytic activity.Chem Res Toxicol. 2008 Dec;21(12):2313-23. doi: 10.1021/tx8002998. Chem Res Toxicol. 2008. PMID: 19548353 Free PMC article.
-
A suite of activity-based probes for human cytochrome P450 enzymes.J Am Chem Soc. 2009 Aug 5;131(30):10692-700. doi: 10.1021/ja9037609. J Am Chem Soc. 2009. PMID: 19583257 Free PMC article.
-
Rethinking glycolysis: on the biochemical logic of metabolic pathways.Nat Chem Biol. 2012 May 17;8(6):509-17. doi: 10.1038/nchembio.971. Nat Chem Biol. 2012. PMID: 22596202 Review.
-
Ethyl 2-[(2-oxo-2H-chromen-6-yl)-oxy]acetate.Acta Crystallogr E Crystallogr Commun. 2024 May 31;80(Pt 6):659-662. doi: 10.1107/S2056989024004729. eCollection 2024 May 1. Acta Crystallogr E Crystallogr Commun. 2024. PMID: 38845711 Free PMC article.
-
Inhibition of CYP2B4 by 2-ethynylnaphthalene: evidence for the co-binding of substrate and inhibitor within the active site.Arch Biochem Biophys. 2007 Dec 15;468(2):174-82. doi: 10.1016/j.abb.2007.07.032. Epub 2007 Oct 4. Arch Biochem Biophys. 2007. PMID: 17967439 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous